Discover Oncology
Overview
Discover Oncology is a scientific journal, published by Springer since 2021 in English. The journal's country of origin is United States and its primary focus area is oncology.
Details
Details
Abbr.
Discov Oncol
Publisher
Springer
Start
2021
End
Continuing
Frequency
Annual
e-ISSN
2730-6011
Country
United States
Language
English
Specialty
Oncology
Metrics
Metrics
h-index / Ranks: 8115
44
SJR / Ranks: 6153
715
CiteScore / Ranks: 9425
2.60
Recent Articles
1.
Xia Y, Wan G, Li S, Hu S, Wu G
Discov Oncol
. 2025 Mar;
16(1):326.
PMID: 40089648
Objective: This study aimed to investigate the causal relationship between inflammatory cytokines and oral cavity cancer risk using Mendelian randomization analysis and experimental validation. Methods: Two-sample Mendelian randomization was conducted...
2.
Zeng F, Chen L, Li J, Yu W, Sa N, Zhang K, et al.
Discov Oncol
. 2025 Mar;
16(1):323.
PMID: 40088376
Purpose: To investigate the expression and clinical significance of insulin-like growth factor 2 mRNA-binding protein family members (IGF2BPs) in pan-cancer and evaluate their potential as targets for tumor immunotherapy. Methods:...
3.
Xie Y, Zhang S, Wu Y, Qi Y, Qi S, Chen X, et al.
Discov Oncol
. 2025 Mar;
16(1):322.
PMID: 40088361
Background: The phospholipid-modifying enzyme MBOAT2 plays a crucial role in iron homeostasis by inhibiting iron sequestration, thus preventing iron-induced cell death. It achieves this by remodeling the phospholipid composition of...
4.
Shi D, Chen L, Li C, Yang M, Yang W, Cui G, et al.
Discov Oncol
. 2025 Mar;
16(1):325.
PMID: 40088359
Objective: The study aims to evaluate the role and mechanism of action of vitamin C as an anti- Epstein-Barr virus (EBV) and papillary thyroid carcinoma (PTC) therapeutic agent. Methods: The...
5.
Gu J, Wang Y, Zhang H, Gu H, Zhu H
Discov Oncol
. 2025 Mar;
16(1):324.
PMID: 40088346
Background: Colonic adenocarcinoma (COAD) is the most common pathological type of colon cancer. Tumor microenvironment (TME) plays an important role in the occurrence and development of COAD. There are currently...
6.
Zhang X, Xue H, Lv Y, Zhou Y, Sha K, Liu T
Discov Oncol
. 2025 Mar;
16(1):320.
PMID: 40088344
Introduction: The TOR signaling pathway regulator-like (TIPRL) gene plays a multifaceted role in cancer, yet its pan-cancer profile remains underexplored. This study investigates TIPRL expression across multiple cancers and its...
7.
Geng X, Jiang Y, Zeng Y, Cao W, Lu Y, Liang Y, et al.
Discov Oncol
. 2025 Mar;
16(1):321.
PMID: 40088301
Background: Lung cancer is the most prevalent malignancy worldwide. Only a fraction of early-stage patients undergo radical surgery; however, many still experience recurrence and metastasis within 5 years postoperatively (approximately...
8.
Liu P, Zhang Q, Liu F
Discov Oncol
. 2025 Mar;
16(1):319.
PMID: 40087210
Epithelial cell adhesion molecule (EpCAM) is an important biomarker in tumors. In hepatocellular carcinoma (HCC), EpCAM + cells exhibit high invasiveness, tumorigenic ability, therapeutic resistance, and self-renewal ability, often identified...
9.
Li R, Zhang H, Li Y, Yao X, Dong X, Xu Y, et al.
Discov Oncol
. 2025 Mar;
16(1):316.
PMID: 40085398
Background: Patients with advanced pulmonary large-cell neuroendocrine carcinoma (LCNEC) have a progressive clinical course and poor prognosis, and effective treatment options remain limited. This study assessed the efficacy and safety...
10.
Zeng C, Xu C, Liu S, Wang Y, Wei Y, Qi Y, et al.
Discov Oncol
. 2025 Mar;
16(1):318.
PMID: 40085377
Breast cancer is the second most prevalent malignant tumor worldwide and is highly heterogeneous. Cuproptosis, a newly identified form of cell death, is intimately connected to lipid metabolism. This study...